Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Norfloxacin → 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[4-(1-chloroethoxy carbonyl)-1-piperazinyl]-3-quinoline carboxylic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Norfloxacin | HCID 4539 | — |
| 반응물 | Proton sponge | HCID 88675 | — |
| 반응물 | 1-Chloroethyl chloroformate | HCID 521305 | — |
| 용매 | Chloroform | HCID 6212 | — |
| 생성물 | 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-[4-(1-chloroethoxy carbonyl)-1-piperazinyl]-3-quinoline carboxylic acid | HCID 14801295 | — |
반응 단계
Norfloxacin (6.4 g) was suspended in 300 ml of chloroform and 4.3 g of proton sponge® was added to it. The suspension was cooled in an ice bath and 4.0 g of 1-chloroethyl chloroformate was added. A clear solution resulted in half an hour. The reaction mixture was stirred at room temperature for 14 hours. The reaction mixture was concentrated in vacuum to about 150 ml. The crystals formed were filtered and washed with chloroform. The pure product weighed 5.3 g.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US04760057 |
| 출처 데이터셋 | uspto-grants-1988_07 |
| ORD ID | ord-d21d2f084c1942dc921e756a6a7f225b |
| 출처 메모 | uspto-grants-1988_07 |